scAAV1.tMCK.NTF3
/ Nationwide Children's, Sarepta Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 27, 2025
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
(clinicaltrials.gov)
- P1/2 | N=3 | Not yet recruiting | Sponsor: Nationwide Children's Hospital | Trial primary completion date: Apr 2028 ➔ Apr 2029
Trial primary completion date • Genetic Disorders • Pain
May 01, 2024
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
(clinicaltrials.gov)
- P1/2 | N=3 | Suspended | Sponsor: Nationwide Children's Hospital | Trial completion date: Jul 2024 ➔ Apr 2030 | Trial primary completion date: Mar 2024 ➔ Apr 2028
Trial completion date • Trial primary completion date • Genetic Disorders • Pain
March 14, 2023
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
(clinicaltrials.gov)
- P1/2 | N=3 | Suspended | Sponsor: Nationwide Children's Hospital | Trial completion date: Jul 2023 ➔ Jul 2024 | Trial primary completion date: Mar 2023 ➔ Mar 2024
Trial completion date • Trial primary completion date • Genetic Disorders • Pain
1 to 3
Of
3
Go to page
1